Nevisense is now commercially available in Belgium, Great Britain, Germany, Australia, Austria, Switzerland, Nordic markets, and the US. For more information regarding sales and ordering in these markets either e-mail us at order@scibase.com or contact one of our representatives below:

GERMANY

Dr. Emanuel von Kienlin, Managing Director (based in Munich, Germany) E-mail: emanuel.vonkienlin@scibase.com Phone: +49-172-823 3386
Katja Hardies Sales West Germany (based in Cologne, Germany) E-mail: katja.hardies@scibase.com Phone: +49-176-187 90950
Ralf Anton Sales Agent North/Central/East Germany (based in Freigericht, Germany)  E-mail: ralf.anton@scibase.com Phone: +49-170-5705423

For the German site, please click here.

AUSTRALIA

E3 Health Pty Ltd, Tel: +61 433 996 344, Website: https://e3health.com.au/
Postal Address: PO Box 591, Church Point, NSW, 2105 Australia

AUSTRIA

Intramed Tel: +43 (1) 876 0101 Website: www.intramed.at E-Mail: office@intramed.at

SWITZERLAND

Tobias Bergenblad, Global Sales Director (based in Sweden), Tel: +46 732 06 98 14 Email: tobias.bergenblad@scibase.com

GREAT BRITAIN

Globe AMT Tel: +44 1372 471 100 Website: www.globeamt.com E-mail: info@globeamt.com

BELGIUM

Dermat Medical Supplies Tel: +32 (0) 16/40 05 45 Website: www.dermat.be E-mail: info@dermat.be

NORDIC

Tobias Bergenblad, Global Sales Director (based in Sweden), Tel: +46 732 06 98 14 Email: tobias.bergenblad@scibase.com

UNITED STATES

Email: us-sales@scibase.com   For a selection of clinics offering Nevisense, click here

UPCOMING LAUNCHES

This page will be continually updated with market specific details as Nevisense is launched in each respective market.